APA (7th ed.) Citation

Yan, Q., & Liu, J. Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies. Ferrata Storti Foundation.

Chicago Style (17th ed.) Citation

Yan, Qian, and Jinlin Liu. Comment on: FLT3 Ligand Kinetic Profile Predicts Response to Treatment in Patients with High-risk Myelodysplastic Syndrome / Chronic Myelomonocytic Leukemia Receiving CPX-351: A Study from the Groupe Francophone Des Myélodysplasies. Ferrata Storti Foundation.

MLA (9th ed.) Citation

Yan, Qian, and Jinlin Liu. Comment on: FLT3 Ligand Kinetic Profile Predicts Response to Treatment in Patients with High-risk Myelodysplastic Syndrome / Chronic Myelomonocytic Leukemia Receiving CPX-351: A Study from the Groupe Francophone Des Myélodysplasies. Ferrata Storti Foundation.